Amphotericin B Market Trends in Q2 2025: Regional Price Shifts in North America, China, and Germany
The global Amphotericin B market experienced significant volatility during the second quarter of 2025, shaped by a complex interplay of trade dynamics, supply chain realignments, and shifting demand fundamentals. This antifungal agent—widely used in the treatment of systemic fungal infections—remains a critical active pharmaceutical ingredient (API) within the healthcare sector. Across key regions such as North America, China, and Germany , the pricing trends for Amphotericin B demonstrated divergent trajectories, reflecting the regionalized nature of pharmaceutical trade and policy. While the United States grappled with tariff uncertainties and excess inventories, China witnessed a prolonged price dip followed by a modest recovery, and Germany endured a supply glut as redirected shipments flooded its domestic market. This article delves into the regional market dynamics of Amphotericin B, highlights the drivers behind price movements, and explores the potential outlook for the re...